Stockwinners

Happy Holidays from all of us at Stockwinners

https://www.stockwinners.com/blog/2023/09/21/splunk-sold-for-28-billion/

$SPLK $CSCO

Splunk sold for $28 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on September 21, 2023 by Stockwinners ComSplunk sold for $28 billion Cisco to acquire Splunk for $157 per share in cash, or $28B EV Cisco (CSCO) and Splunk (SPLK) announced a definitive agreement under which Cisco intends to acquire Splunk for $157 per share in cash, representing approximatel...

https://www.stockwinners.com/blog/2023/09/08/burford-capital-shares-soar-on-its-court-victory/
$BUR $YPF

Burford Capital Shares Soar on it’s Court Victory – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on September 8, 2023 by Stockwinners ComBurford Capital Shares Soar on it’s Court Victory Argentina ordered to pay at least $8.4B in YPF suit with claims owned by Burford Argentina was ordered to pay at least $8.4B in damages in a U.S. lawsuit over its 2012 re-nationalization of state oil c...

https://www.stockwinners.com/blog/2023/07/28/reata-pharmaceuticals-sold-for-7-3b/
$BIIB $RETA #

Reata Pharmaceuticals sold for $7.3B – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on July 28, 2023 by Stockwinners ComReata Pharmaceuticals sold for $7.3B Biogen to acquire Reata Pharmaceuticals for $172.50 per share in cash Biogen Inc. (BIIB) and Reata Pharmaceuticals (RETA) announced the companies have entered into a definitive agreement under which Biogen has agreed to....

https://www.stockwinners.com/blog/2023/06/12/adenza-sold-for-10-5-billion/
$NDAQ

Adenza sold for $10.5 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on June 12, 2023 by Stockwinners ComAdenza sold for $10.5 billion Nasdaq to acquire Adenza from Thoma Bravo for $10.5B in cash and stock Nasdaq (NDAQ) announced it has entered into a definitive agreement to acquire Adenza, a provider of mission-critical risk management and regulatory software...

https://www.stockwinners.com/blog/2023/06/06/pga-tour-and-liv-golf-to-merge-ending-lawsuits/
$GOLF $MODG $NKE

PGA TOUR and LIV Golf to Merge, Ending Lawsuits – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on June 6, 2023 by Stockwinners ComPGA TOUR and LIV Golf to Merge, Ending Lawsuits PGA TOUR confirms deal to merge with LIV Golf The PGA TOUR, DP World Tour (formerly known as the European Tour) and the Public Investment Fund announced a landmark agreement to unify the game of golf, on a glob...

Rig Counts declined last week.

$COP, $CVX, $XOM, OIL, OPEC, REFINERY, RIG COUNTS, STOCK ADVISORY, STOCKWINNERS

Rig Counts declined last week! – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on May 26, 2023 by Stockwinners ComRig Counts declined last week! Baker Hughes reports U.S. rig count down 9 to 711 rigs. Baker Hughes (BKR) reports that the U.S. rig count is down 9 from last week to 711 with oil rigs down 5 to 570, gas rigs down 4 to 137 and miscellaneous rigs unchanged at....

https://www.stockwinners.com/blog/2023/05/22/japans-mizuho-financial-buys-greenhill/

Japan’s Mizuho Financial buys Greenhill – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on May 22, 2023 by Stockwinners ComJapan’s Mizuho Financial buys Greenhill Mizuho Financial Group to acquire Greenhill & Co. for $15 per share in cash Mizuho Financial Group, Inc. (MFG) and Greenhill & Co., Inc. (GHL) announced a definitive agreement for Mizuho to acquire Greenhill in an al...

https://www.stockwinners.com/blog/2023/05/19/krystal-biotech-shares-jump-as-fda-approves-vyjuvek/

Krystal Biotech shares jump as FDA approves Vyjuvek – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on May 19, 2023 by Stockwinners ComKrystal Biotech shares jump as FDA approves Vyjuvek Vyjuvek is designed to treat the genetic root cause of DEB Krystal Biotech (KRYS) announced the U.S. Food and Drug Administration has approved Vyjuvek for the treatment of patients six months of age or olde...

https://www.stockwinners.com/blog/2023/05/03/eli-lilly-shares-higher-on-alzheimers-drug/
$LLY $BIIB

Eli Lilly Shares Higher on Alzheimer’s Drug! – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on May 3, 2023 by Stockwinners ComEli Lilly Shares Higher on Alzheimer’s Drug! Eli Lilly TRAILBLAZER-ALZ 2 met primary endpoint, all secondary endpoint Eli Lilly (LLY) announced results of the TRAILBLAZER-ALZ 2 Phase 3 study showing that donanemab significantly slowed cognitive and function...